Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 StudyEvan S. Dellon, Siddhesh Kamat, Qiong Zhao et al.|Journal of Allergy and Clinical Immunology|2021Cited by 13
Validation of the novel Eosinophilic Esophagitis Impact QuestionnaireEilish McCann, Siddhesh Kamat, Mirna Chehade et al.|Journal of Patient-Reported Outcomes|2023Cited by 9
S415 Increasing Prevalence of Eosinophilic Esophagitis in the United States from 2015 to 2018Siddhesh Kamat, Mirna Chehade, Jessica J. Jalbert et al.|The American Journal of Gastroenterology|2021Cited by 3